SUBSCRIBE
SUBSCRIBE

DNA Script

NEWS
Drug Development
How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
June 4, 2020
 · 
19 min read
 · 
Chelsea Weidman Burke, M.S.
Load More
IN THE PRESS
Biotech Bay
DNA Script to Present at 40th Annual J.P. Morgan Healthcare Conference
January 5, 2022
 · 
1 min read
Biotech Bay
DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche
January 4, 2022
 · 
2 min read
Biotech Bay
DNA Script Obtains CE Mark for SYNTAX DNA Printing Platform
November 30, 2021
 · 
2 min read
Business
DNA Script Welcomes Blanche Savary de Beauregard as General Counsel
November 16, 2021
 · 
2 min read
Biotech Bay
DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH
November 9, 2021
 · 
4 min read
Biotech Bay
DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform
October 26, 2021
 · 
3 min read
Business
DNA Script Appoints Don Kania as Chairman of the Board of Directors, Catherine Moukheibir as Audit Chair and Bonnie Anderson as Independent Director
October 21, 2021
 · 
3 min read
Biotech Bay
DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis
May 20, 2021
 · 
3 min read
Business
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
April 27, 2021
 · 
2 min read
Biotech Bay
DNA Script Signs Innovation Development Contract With French Defence Innovation Agency to Enable On-Demand Diagnostics Against Emerging Biothreats
January 28, 2021
 · 
2 min read
Load More
JOBS